The purpose of the present invention is to provide a swelling inhibitor-type virus for treating tumors. Provided are: an oncolytic virus having a gene that encodes a vascular endothelial growth factor (VEGF) antagonist； and a pharmaceutical composition for treating tumors that contains the oncolytic virus.
